Anti-FBXL17 monoclonal antibody
Pre-made anti-FBXL17 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to FBXL17/FBXL17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0836-Ab-1/ GM-Tg-hg-IP0836-Ab-2 | Anti-Human FBXL17 monoclonal antibody | Human |
GM-Tg-rg-IP0836-Ab-1/ GM-Tg-rg-IP0836-Ab-2 | Anti-Rat FBXL17 monoclonal antibody | Rat |
GM-Tg-mg-IP0836-Ab-1/ GM-Tg-mg-IP0836-Ab-2 | Anti-Mouse FBXL17 monoclonal antibody | Mouse |
GM-Tg-cynog-IP0836-Ab-1/ GM-Tg-cynog-IP0836-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FBXL17 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0836-Ab-1/ GM-Tg-felg-IP0836-Ab-2 | Anti-Feline FBXL17 monoclonal antibody | Feline |
GM-Tg-cang-IP0836-Ab-1/ GM-Tg-cang-IP0836-Ab-2 | Anti-Canine FBXL17 monoclonal antibody | Canine |
GM-Tg-bovg-IP0836-Ab-1/ GM-Tg-bovg-IP0836-Ab-2 | Anti-Bovine FBXL17 monoclonal antibody | Bovine |
GM-Tg-equg-IP0836-Ab-1/ GM-Tg-equg-IP0836-Ab-2 | Anti-Equine FBXL17 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0836-Ab-1/ GM-Tg-hg-IP0836-Ab-2; GM-Tg-rg-IP0836-Ab-1/ GM-Tg-rg-IP0836-Ab-2; GM-Tg-mg-IP0836-Ab-1/ GM-Tg-mg-IP0836-Ab-2; GM-Tg-cynog-IP0836-Ab-1/ GM-Tg-cynog-IP0836-Ab-2; GM-Tg-felg-IP0836-Ab-1/ GM-Tg-felg-IP0836-Ab-2; GM-Tg-cang-IP0836-Ab-1/ GM-Tg-cang-IP0836-Ab-2; GM-Tg-bovg-IP0836-Ab-1/ GM-Tg-bovg-IP0836-Ab-2; GM-Tg-equg-IP0836-Ab-1/ GM-Tg-equg-IP0836-Ab-2 |
Products Name | Anti-FBXL17 monoclonal antibody |
Format | mab |
Target Name | FBXL17 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-FBXL17 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0836-Ag-1 | Recombinant multi-species FXL17/ FBXL17/ FBXO13 protein |
Target information
Target ID | GM-IP0836 |
Target Name | FBXL17 |
Gene ID | 64839,50758,316663,106992307,608166,101093990,523504,100146140 |
Gene Symbol and Synonyms | 6330576B01Rik,C130023C01Rik,Fbl17,Fbx13,FBXL17,FBXO13 |
Uniprot Accession | Q9UF56 |
Uniprot Entry Name | FXL17_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000145743 |
Target Classification | N/A |
The target: FBXL17, gene name: FBXL17, also named as FBXO13, Fbl17, Fbx13. Members of the F-box protein family, such as FBXL17, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.